Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

Clinical trial NCT00969436 · COMPLETED

Trial details

NCT number: NCT00969436
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Varicella Rubella Mumps Measles

Start date: 2009-11-09
Primary completion: 2011-02-21
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.